Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Bamrah Morris, Sapna ; Belknap, Robert ; Buchta, William ; Casey, Megan L. ; Goswami, Neela D. ; Gruden, MaryAnn ; Hurst, Bobbi Jo ; Khan, Amera R. ; Kuhar, David T. ; Lewinsohn, David M. ; Lobato, Mark N. ; Mathew, Trini A. ; Mazurek, Gerald H. ; Njie, Gibril J. ; Paulos, Lisa ; Reves, Randall ; Sosa, Lynn E. ; Thanassi, Wendy ; Will, Lorna
• Corporate Authors:
  National Tuberculosis Controllers Association ; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) Division of Tuberculosis Elimination ; National Institute for Occupational Safety and Health. Respiratory Health Division ; National Center for Emerging and Zoonotic Infectious Diseases (U.S.) Division of Healthcare Quality Promotion
• Description:
  The 2005 CDC guidelines for preventing Mycobacterium Tuberculosis Transmission in health care settings include recommendations for baseline Tuberculosis (TB) screening of all U.S. health care personnel and annual tTesting for health care personnel working in medium-risk settings or settings with potential for ongoing Transmission (1). Using evidence from a systematic review conducted by a National Tuberculosis Controllers Association (NTCA)-CDC work group, and following Methods adapted from the Guide to Community Preventive Services (2,3), the 2005 CDC recommendations for tTesting U.S. health care personnel have been updated and now include 1) TB screening with an individual risk assessment and symptom evaluation at baseline (preplacement); 2) TB tTesting with an interferon-Gamma release assay (IGRA) or a tuberculin skin test (TST) for persons without documented prior TB disease or latent TB infection (LTBI); 3) no routine serial TB tTesting at any interval after baseline in the absence of a known exposure or ongoing Transmission; 4) encouragement of treatment for all health care personnel with untreated LTBI, unless treatment is contraindicated; 5) annual symptom screening for health care personnel with untreated LTBI; and 6) annual TB education of all health care personnel.
• Subjects:
  Full Report Health Personnel Interferon-Gamma Release Tests Latent Tuberculosis Mass Screening Mycobacterium Tuberculosis Occupational Health Risk Assessment Systematic Reviews As Topic Tuberculin Test Tuberculosis

  More +
• Source:
  MMWR Morbidity Mortal Weekly Rep. 68(19):439-443
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Publisher:
  Centers for Disease Control and Prevention (CDC) (U.S.)
• Pubmed ID:
  31099768
• Pubmed Central ID:
  PMC6522077
• Document Type:
  Text
• Genre:
  Journal Article
• Place as Subject:
  United States
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Division:
  RHD - Respiratory Health Division
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  5 pdf pages
• Volume:
  68
• Issue:
  19
• NIOSHTIC Number:
  nn:20055854
• Collection(s):
  National Institute for Occupational Safety and Health Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:fc39fd1ae0698de74352266dbb955791362c2c99420cff98e2061d38bfcd5588b498fc97411e3aef15cf179ed31caefb4d688211a9992a060c75dc46de44b450
• Download URL:
  https://stacks.cdc.gov/view/cdc/78840/cdc_78840_DS1.pdf
• File Type:
  [PDF - 173.08 KB ]